Kinetics of immune tolerization in a clinical trial on epitope-specific therapy in rheumatoid arthritis (RA)

被引:0
|
作者
Koffeman, Eva
Amox, Diane
Tremoulet, Adriana
Keogh, Elissa
Zeiseniss, Peter
Gosch, Courtney
Friend, Samantha
Zhang, Xiao
Cutter, Gary
Albani, Salvatore
机构
[1] Univ Calif San Diego, Dept Med & Pediat, Utrecht, Netherlands
[2] Univ Alabama, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA
关键词
D O I
10.1016/j.clim.2007.03.454
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S96 / S97
页数:2
相关论文
共 50 条
  • [1] Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis
    Billetta, Rosario
    Ghahramani, Negar
    Morrow, Olivia
    Prakken, Berent
    de Jong, Huib
    Meschter, Carol
    Lanza, Paola
    Albani, Salvatore
    CLINICAL IMMUNOLOGY, 2012, 145 (02) : 94 - 101
  • [2] Epitope-specific immunotherapy in rheumatoid arthritis
    Albani, S
    Bathon, J
    Belardi, F
    Berry, C
    Dennehey, C
    Firestein, G
    Genovese, M
    Kavanaugh, A
    Martinez, A
    Matteson, E
    Molitor, J
    Posever, J
    Santana, E
    Samodal, R
    Schiff, M
    IMMUNOLOGY, 2005, 116 : 43 - 44
  • [3] Epitope-specific therapy in rheumatoid arthritis, phase 2 clinical and immunological results.
    Koffeman, Eva
    Amox, Diane
    Genovese, Mark
    Schiff, Michael
    Dennehey, Carolyn
    Posever, James
    Belardi, Francis
    Santana, Ernesto
    Molitor, Jerry
    Bathon, Joan
    Matteson, Eric
    Kivitz, Allan
    Berry, Charles
    Keogh, Elissa
    Yung, Gisella Puga
    Tremoulet, Adriana
    Zieseniss, Peter
    Gosch, Courtney
    Friend, Samantha
    Martinez, Alex
    Le, Tho
    Samodal, Rodrigo
    Kavanaugh, Arthur
    Sriuma, Jearanai
    Zhang, Xiao
    Prakken, Berent
    Cutter, Gary
    Albani, Salvatore
    CLINICAL IMMUNOLOGY, 2006, 119 : S4 - S5
  • [4] Phase II trial of epitope-specific immunotherapy in rheumatoid arthritis.
    Albani, S
    Tremoulet, A
    Genovese, M
    Schiff, M
    Dennehey, C
    Posever, J
    Belardi, F
    Santana, E
    Molitor, J
    Bathon, J
    Matteson, E
    Kavanaugh, A
    Martinez, A
    Amox, D
    Keogh, E
    Berry, C
    Cutter, G
    Puga-Yung, G
    Gosch, C
    Koffeman, E
    Friend, S
    Zieseniss, P
    Samodal, R
    Le, T
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4059 - 4059
  • [5] Induction of Immune Tolerance through an Epitope-Specific Vaccine Induces Clinical Amelioration in Patients with Rheumatoid Arthritis
    Chan, Jin Hui Sherlynn
    van den Broek, Theodorus
    Leong, Jing Yao
    Rossetti, Maura
    Spreafico, Roberto
    Albani, Salvatore
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Clinical and immunological effects of epitope-specific therapy in rheumatoid arthritis (RA): Synergistic effect of dnaJP1 with Hydroxy-chloroquine (HCQ).
    Koffeman, E.
    Amox, D.
    Genovese, M.
    Kavanaugh, A.
    Schiff, M.
    Santana, E.
    Dennehey, C.
    Posever, J.
    Belardi, F.
    Molitor, J.
    Bathon, J.
    Matteson, E.
    Kivitz, A.
    Berry, C.
    Keogh, E.
    Yung, G. Puga
    Tremoulet, A.
    Zieseniss, P.
    Gosch, C.
    Friend, S.
    Martinez, A.
    Le, T.
    Samodal, S.
    Cutter, G.
    Albani, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S244 - S244
  • [7] Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
    Prakken, BJ
    Samodal, R
    Le, TD
    Giannoni, F
    Yung, GP
    Scavulli, J
    Amox, D
    Roord, S
    de Kleer, I
    Bonnin, D
    Lanza, P
    Berry, C
    Massa, M
    Billetta, R
    Albani, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) : 4228 - 4233
  • [8] Epigenetic Features As Predictive Markers of Responsiveness to Epitope-Specific Therapy in Rheumatoid Arthritis.
    Spreafico, Roberto
    Rossetti, Maura
    Van Der Broek, Theodorus
    Morrow, Olivia
    Albani, Salvatore
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S185 - S186
  • [9] REACTIVATION OF IMMUNE CHECKPOINTS BY AN EPITOPE-SPECIFIC VACCINE REINSTATES TOLEROGENIC PATHWAYS AND INDUCES CLINICAL AMELIORATION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Chan, J. H. S.
    van den Broek, T.
    Leong, J. Y.
    Rossetti, M.
    Spreafico, R.
    Albani, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 977 - 977
  • [10] T cell epitope-specific immune therapy for rheumatic diseases
    Albani, S
    Prakken, B
    ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 19 - 25